Liver zonation: Novel aspects of its regulation and its impact on homeostasis

World Journal of Gastroenterology

Volumn , Issue 26, 2014, Pages 8491-8504

  Gebhardt, Rolf ^a   Matz Soja, Madlen ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Homeostasis; Liver; Metabolic zonation; Metabolism; Morphogen signalling; Optimization; Pathology; Regulatory network; Sinusoid; Systems biology

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN; FIBROBLAST GROWTH FACTOR; MORPHOGEN; RAS PROTEIN; SCATTER FACTOR; SONIC HEDGEHOG PROTEIN; TRANSFORMING GROWTH FACTOR;

AUTOPHAGY; CARBOHYDRATE METABOLISM; DONATION; DRUG METABOLISM; ENERGY METABOLISM; GENE EXPRESSION; HOMEOSTASIS; HUMAN; LIVER DONATION; LIVER FUNCTION; LIVER METABOLISM; LIVER PARENCHYMA; LIVER SINUSOID; METABOLIC DISORDER; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; WNT SIGNALING PATHWAY; ANTIOXIDANT ACTIVITY; CIRCADIAN RHYTHM; HEDGEHOG SIGNALLING; LIVER ZONATION; MITOCHONDRION; NONHUMAN; NUTRITION; SEX DIFFERENCE; ANIMAL; BIOTRANSFORMATION; LIVER; LIVER DISEASE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; BIOTRANSFORMATION; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; LIVER; LIVER DISEASES; SIGNAL TRANSDUCTION;

EID: 84904382731     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i26.8491     Document Type: Review

References (132)

1. Sasse D. Liver Structure and Innervation. In: Thurman RG, editor. Regulation of hepatic metabolism: Intra- and intercellular compartmentation. New York: Plenum Press, 1986: 3-25
2. Ekataksin W, Kaneda K. Liver microvascular architecture: an insight into the pathophysiology of portal hypertension. Semin Liver Dis 1999; 19: 359-382 [PMID: 10643623 DOI: 10.1055/s-2007-1007126] (Pubitemid 30032639)
3. Lamers WH, Hilberts A, Furt E, Smith J, Jonges GN, van Noorden CJ, Janzen JW, Charles R, Moorman AF. Hepatic enzymic zonation: a reevaluation of the concept of the liver acinus. Hepatology 1989; 10: 72-76 [PMID: 2472341] (Pubitemid 19170006)
4. Jungermann K, Sasse D. Heterogeneity of liver parenchymal cells. Trends Biochem Sci 1978; 3: 198-202 [DOI: 10.1016/S0968-0004(78)91764-4] (Pubitemid 9011796)
5. Jungermann K. Metabolic zonation of liver parenchyma. Semin Liver Dis 1988; 8: 329-341 [PMID: 3062788 DOI: 10.1055/s-2008-1040554] (Pubitemid 19045631)
6. Gebhardt R. Metabolic zonation of the liver: regulation and implications for liver function. Pharmacol Ther 1992; 53: 275-354 [PMID: 1409850]
7. Jungermann K, Kietzmann T. Oxygen: modulator of metabolic zonation and disease of the liver. Hepatology 2000; 31: 255-260 [PMID: 10655244 DOI: 10.1002/hep.510310201] (Pubitemid 30078586)
8. Benhamouche S, Decaens T, Godard C, Chambrey R, Rickman DS, Moinard C, Vasseur-Cognet M, Kuo CJ, Kahn A, Perret C, Colnot S. Apc tumor suppressor gene is the "zonation-keeper" of mouse liver. Dev Cell 2006; 10: 759-770 [PMID: 16740478 DOI: 10.1016/j.devcel.2006.03.015] (Pubitemid 43796151)
9. Gebhardt R, Baldysiak-Figiel A, Krügel V, Ueberham E, Gaunitz F. Hepatocellular expression of glutamine synthetase: an indicator of morphogen actions as master regulators of zonation in adult liver. Prog Histochem Cytochem 2007; 41: 201-266 [PMID: 17368308 DOI: 10.1016/j.proghi.2006.12.001] (Pubitemid 46412421)
10. Matz-Soja M, Hovhannisyan A, Gebhardt R. Hedgehog signalling pathway in adult liver: a major new player in hepatocyte metabolism and zonation? Med Hypotheses 2013; 80: 589-594 [PMID: 23433827 DOI: 10.1016/j.mehy.2013.01.032]
11. Saito K, Negishi M, James Squires E. Sexual dimorphisms in zonal gene expression in mouse liver. Biochem Biophys Res Commun 2013; 436: 730-735 [PMID: 23791742 DOI: 10.1016/j.bbrc.2013.06.025]
12. Gebhardt R. Isolation of periportal and pericentral hepatocytes. Methods Mol Biol 1998; 107: 319-328 [PMID: 14577241]
13. Debois D, Bralet MP, Le Naour F, Brunelle A, Laprévote O. In situ lipidomic analysis of nonalcoholic fatty liver by cluster TOF-SIMS imaging. Anal Chem 2009; 81: 2823-2831 [PMID: 19296690 DOI: 10.1021/ac900045m]
14. Wattacheril J, Seeley EH, Angel P, Chen H, Bowen BP, Lanciault C, Caprioli RM, Abumrad N, Flynn CR. Differential intrahepatic phospholipid zonation in simple steatosis and nonalcoholic steatohepatitis. PLoS One 2013; 8: e57165 [PMID: 23451176 DOI: 10.1371/journal.pone.0057165]
15. Ke R, Mignardi M, Pacureanu A, Svedlund J, Botling J, Wählby C, Nilsson M. In situ sequencing for RNA analysis in preserved tissue and cells. Nat Methods 2013; 10: 857-860 [PMID: 23852452 DOI: 10.1038/nmeth.2563]
16. Gebhardt R, Mecke D. Heterogeneous distribution of glutamine synthetase among rat liver parenchymal cells in situ and in primary culture. EMBO J 1983; 2: 567-570 [PMID: 6138251]
17. Cooke J. Morphogens in vertebrate development: how do they work? Bioessays 1995; 17: 93-96 [PMID: 7748169 DOI: 10.1002/bies.950170202]
18. Tabata T, Takei Y. Morphogens, their identification and regulation. Development 2004; 131: 703-712 [PMID: 14757636 DOI: 10.1242/dev.01043] (Pubitemid 38263187)
19. Huch M, Dorrell C, Boj SF, van Es JH, Li VS, van de Wetering M, Sato T, Hamer K, Sasaki N, Finegold MJ, Haft A, Vries RG, Grompe M, Clevers H. In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration. Nature 2013; 494: 247-250 [PMID: 23354049 DOI: 10.1038/nature11826]
20. Thompson MD, Monga SP. WNT/beta-catenin signaling in liver health and disease. Hepatology 2007; 45: 1298-1305 [PMID: 17464972 DOI: 10.1002/hep.21651] (Pubitemid 46775794)
21. Varjosalo M, Taipale J. Hedgehog: functions and mechanisms. Genes Dev 2008; 22: 2454-2472 [PMID: 18794343 DOI: 10.1101/gad.1693608]
22. Ashe HL, Briscoe J. The interpretation of morphogen gradients. Development 2006; 133: 385-394 [PMID: 16410409 DOI: 10.1242/dev.02238] (Pubitemid 43273825)
23. Wartlick O, Kicheva A, González-Gaitán M. Morphogen gradient formation. Cold Spring Harb Perspect Biol 2009; 1: a001255 [PMID: 20066104 DOI: 10.1101/cshperspect.a001255]
24. Gurdon JB, Bourillot PY. Morphogen gradient interpretation. Nature 2001; 413: 797-803 [PMID: 11677596 DOI: 10.1038/35101500] (Pubitemid 33026841)
25. Loeppen S, Schneider D, Gaunitz F, Gebhardt R, Kurek R, Buchmann A, Schwarz M. Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital. Cancer Res 2002; 62: 5685-5688 [PMID: 12384525] (Pubitemid 35204722)
26. Cadoret A, Ovejero C, Terris B, Souil E, Lévy L, Lamers WH, Kitajewski J, Kahn A, Perret C. New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism. Oncogene 2002; 21: 8293-8301 [PMID: 12447692 DOI: 10.1038/sj.onc.1206118] (Pubitemid 35477869)
27. Burke ZD, Tosh D. The Wnt/beta-catenin pathway: master regulator of liver zonation? Bioessays 2006; 28: 1072-1077 [PMID: 17041892 DOI: 10.1002/bies.20485] (Pubitemid 44714116)
28. Gebhardt R, Hovhannisyan A. Organ patterning in the adult stage: the role of Wnt/beta-catenin signaling in liver zonation and beyond. Dev Dyn 2010; 239: 45-55 [PMID: 19705440]
29. Inagaki T, Choi M, Moschetta A, Peng L, Cummins CL, McDonald JG, Luo G, Jones SA, Goodwin B, Richardson JA, Gerard RD, Repa JJ, Mangelsdorf DJ, Kliewer SA. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2005; 2: 217-225 [PMID: 16213224 DOI: 10.1016/j.cmet.2005.09.001]
30. Fukumoto S. Actions and mode of actions of FGF19 sub-family members. Endocr J 2008; 55: 23-31 [PMID: 17878606] (Pubitemid 351520176)
31. Casanovas G, Mleczko-Sanecka K, Altamura S, Hentze MW, Muckenthaler MU. Bone morphogenetic protein (BMP)-responsive elements located in the proximal and distal hepcidin promoter are critical for its response to HJV/BMP/SMAD. J Mol Med (Berl) 2009; 87: 471-480 [PMID: 19229506 DOI: 10.1007/s00109-009-0447-2]
32. Mleczko-Sanecka K, Casanovas G, Ragab A, Breitkopf K, Müller A, Boutros M, Dooley S, Hentze MW, Muckenthaler MU. SMAD7 controls iron metabolism as a potent inhibitor of hepcidin expression. Blood 2010; 115: 2657-2665 [PMID: 20040761 DOI: 10.1182/blood-2009-09-238105]
33. Pajvani UB, Qiang L, Kangsamaksin T, Kitajewski J, Ginsberg HN, Accili D. Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability. Nat Med 2013; 19: 1054-1060 [PMID: 23832089 DOI: 10.1038/nm.3259]
34. Pajvani UB, Shawber CJ, Samuel VT, Birkenfeld AL, Shulman GI, Kitajewski J, Accili D. Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner. Nat Med 2011; 17: 961-967 [PMID: 21804540 DOI: 10.1038/nm.2378]
35. Valenti L, Mendoza RM, Rametta R, Maggioni M, Kitajewski C, Shawber CJ, Pajvani UB. Hepatic Notch Signalling Correlates with Insulin Resistance and Non-Alcoholic Fatty Liver Disease. Diabetes 2013; 62: 4052-4062 [PMID: 23990360 DOI: 10.2337/db13-0769]
36. Kaibori M, Kwon AH, Oda M, Kamiyama Y, Kitamura N, Okumura T. Hepatocyte growth factor stimulates synthesis of lipids and secretion of lipoproteins in rat hepatocytes. Hepatology 1998; 27: 1354-1361 [PMID: 9581691 DOI: 10.1002/hep.510270523] (Pubitemid 28227864)
37. Goodnough JB, Ramos E, Nemeth E, Ganz T. Inhibition of hepcidin transcription by growth factors. Hepatology 2012; 56: 291-299 [PMID: 22278715 DOI: 10.1002/hep.25615]
38. Cavard C, Colnot S, Audard V, Benhamouche S, Finzi L, Torre C, Grimber G, Godard C, Terris B, Perret C. Wnt/beta-catenin pathway in hepatocellular carcinoma pathogenesis and liver physiology. Future Oncol 2008; 4: 647-660 [PMID: 18922122 DOI: 10.2217/14796694.4.5.647]
39. Torre C, Perret C, Colnot S. Transcription dynamics in a physiological process: β-catenin signaling directs liver metabolic zonation. Int J Biochem Cell Biol 2011; 43: 271-278 [PMID: 19914393 DOI: 10.1016/j.biocel.2009.11.004]
40. Sekine S, Lan BY, Bedolli M, Feng S, Hebrok M. Liver-specific loss of beta-catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice. Hepatology 2006; 43: 817-825 [PMID: 16557553 DOI: 10.1002/hep.21131]
41. Burke ZD, Reed KR, Phesse TJ, Sansom OJ, Clarke AR, Tosh D. Liver zonation occurs through a beta-catenin-dependent, c-Myc-independent mechanism. Gastroenterology 2009; 136: 2316-2324.e1-3 [PMID: 19268669 DOI: 10.1053/j.gastro.2009.02.063]
42. Vasilj A, Gentzel M, Ueberham E, Gebhardt R, Shevchenko A. Tissue proteomics by one-dimensional gel electrophoresis combined with label-free protein quantification. J Proteome Res 2012; 11: 3680-3689 [PMID: 22671763 DOI: 10.1021/pr300147z]
43. Doi Y, Tamura S, Nammo T, Fukui K, Kiso S, Nagafuchi A. Development of complementary expression patterns of E- and N-cadherin in the mouse liver. Hepatol Res 2007; 37: 230-237 [PMID: 17362306 DOI: 10.1111/j.1872-034X.2007.00028.x] (Pubitemid 46403820)
44. Behari J. The Wnt/β-catenin signaling pathway in liver biology and disease. Expert Rev Gastroenterol Hepatol 2010; 4: 745-756 [PMID: 21108594 DOI: 10.1586/egh.10.74]
45. Liu S, Yeh TH, Singh VP, Shiva S, Krauland L, Li H, Zhang P, Kharbanda K, Ritov V, Monga SP, Scott DK, Eagon PK, Behari J. β-catenin is essential for ethanol metabolism and protection against alcohol-mediated liver steatosis in mice. Hepatology 2012; 55: 931-940 [PMID: 22031168 DOI: 10.1002/hep.24766]
46. Montesano R, Matsumoto K, Nakamura T, Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 1991; 67: 901-908 [PMID: 1835669] (Pubitemid 121001504)
47. Zarnegar R, Michalopoulos GK. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol 1995; 129: 1177-1180 [PMID: 7775566]
48. Matsumoto K, Nakamura T. HGF: its organotrophic role and therapeutic potential. Ciba Found Symp 1997; 212: 198-211; discussion 211-214 [PMID: 9524772]
49. Matsumoto K, Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J Biochem 1996; 119: 591-600 [PMID: 8743556] (Pubitemid 26131762)
50. Nakamura T, Sakai K, Nakamura T, Matsumoto K. Hepatocyte growth factor twenty years on: Much more than a growth factor. J Gastroenterol Hepatol 2011; 26 Suppl 1: 188-202 [PMID: 21199531 DOI: 10.1111/j.1440-1746.2010.06549.x]
51. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984; 122: 1450-1459 [PMID: 6477569] (Pubitemid 14073577)
52. Michalopoulos GK. Liver regeneration. J Cell Physiol 2007; 213: 286-300 [PMID: 17559071 DOI: 10.1002/jcp.21172] (Pubitemid 47509705)
53. Monga SP, Pediaditakis P, Mule K, Stolz DB, Michalopoulos GK. Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration. Hepatology 2001; 33: 1098-1109 [PMID: 11343237 DOI: 10.1053/jhep.2001.23786] (Pubitemid 32378208)
54. Imai K, Mine T, Tagami M, Hanaoka K, Fujita T. Zonal differences in effects of HGF/SF and EGF on DNA synthesis in hepatocytes under fed or starved conditions. Am J Physiol 1998; 275: G1394-G1401 [PMID: 9843777]
55. Braeuning A, Ittrich C, Köhle C, Buchmann A, Schwarz M. Zonal gene expression in mouse liver resembles expression patterns of Ha-ras and beta-catenin mutated hepatomas. Drug Metab Dispos 2007; 35: 503-507 [PMID: 17220236 DOI: 10.1124/dmd.106.013656] (Pubitemid 46513275)
56. Hailfinger S, Jaworski M, Braeuning A, Buchmann A, Schwarz M. Zonal gene expression in murine liver: lessons from tumors. Hepatology 2006; 43: 407-414 [PMID: 16496347 DOI: 10.1002/hep.21082]
57. Zeller E, Hammer K, Kirschnick M, Braeuning A. Mechanisms of RAS/β-catenin interactions. Arch Toxicol 2013; 87: 611-632 [PMID: 23483189 DOI: 10.1007/s00204-013-1035-3]
58. Lauth M. RAS and Hedgehog - partners in crime. Front Biosci (Landmark Ed) 2011; 16: 2259-2270 [PMID: 21622175]
59. Guardavaccaro D, Clevers H. Wnt/β-catenin and MAPK signaling: allies and enemies in different battlefields. Sci Signal 2012; 5: pe15 [PMID: 22494969 DOI: 10.1126/scisignal.2002921]
60. Sicklick JK, Li YX, Jayaraman A, Kannangai R, Qi Y, Vivekanandan P, Ludlow JW, Owzar K, Chen W, Torbenson MS, Diehl AM. Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis. Carcinogenesis 2006; 27: 748-757 [PMID: 16339184 DOI: 10.1093/carcin/bgi292]
61. Sicklick JK, Li YX, Choi SS, Qi Y, Chen W, Bustamante M, Huang J, Zdanowicz M, Camp T, Torbenson MS, Rojkind M, Diehl AM. Role for hedgehog signaling in hepatic stellate cell activation and viability. Lab Invest 2005; 85: 1368-1380 [PMID: 16170335 DOI: 10.1038/labinvest.3700349] (Pubitemid 41509385)
62. Yang L, Wang Y, Mao H, Fleig S, Omenetti A, Brown KD, Sicklick JK, Li YX, Diehl AM. Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cells. J Hepatol 2008; 48: 98-106 [PMID: 18022723 DOI: 10.1016/j.jhep.2007.07.032] (Pubitemid 350191986)
63. Omenetti A, Diehl AM. Hedgehog signaling in cholangiocytes. Curr Opin Gastroenterol 2011; 27: 268-275 [PMID: 21423008 DOI: 10.1097/MOG.0b013e32834550b4]
64. Rangwala F, Guy CD, Lu J, Suzuki A, Burchette JL, Abdelmalek MF, Chen W, Diehl AM. Increased production of sonic hedgehog by ballooned hepatocytes. J Pathol 2011; 224: 401-410 [PMID: 21547909 DOI: 10.1002/path.2888]
65. Jung Y, Diehl AM. Non-alcoholic steatohepatitis pathogenesis: role of repair in regulating the disease progression. Dig Dis 2010; 28: 225-228 [PMID: 20460916 DOI: 10.1159/000282092]
66. Kakisaka K, Cazanave SC, Werneburg NW, Razumilava N, Mertens JC, Bronk SF, Gores GJ. A hedgehog survival pathway in 'undead' lipotoxic hepatocytes. J Hepatol 2012; 57: 844-851 [PMID: 22641094 DOI: 10.1016/j.jhep.2012.05.011]
67. Ochoa B, Syn WK, Delgado I, Karaca GF, Jung Y, Wang J, Zubiaga AM, Fresnedo O, Omenetti A, Zdanowicz M, Choi SS, Diehl AM. Hedgehog signaling is critical for normal liver regeneration after partial hepatectomy in mice. Hepatology 2010; 51: 1712-1723 [PMID: 20432255 DOI: 10.1002/hep.23525]
68. Diehl AM. Neighborhood watch orchestrates liver regeneration. Nat Med 2012; 18: 497-499 [PMID: 22481408 DOI: 10.1038/nm.2719]
69. Diehl AM, Chute J. Underlying potential: cellular and molecular determinants of adult liver repair. J Clin Invest 2013; 123: 1858-1860 [PMID: 23635782 DOI: 10.1172/JCI69966]
70. Matz-Soja M, Aleithe S, Marbach E, Böttger J, Arnold K, Schmidt-Heck W, Kratzsch J, Gebhardt R. Hepatic Hedgehog signalling contributes to the regulation of IGF-I and IGFBP-1 serum levels. Cell Commun Signal 2014; 12; 11 [PMID: 24548465 DOI: 10.1186/1478-811X-12-11]
71. Reed KR, Athineos D, Meniel VS, Wilkins JA, Ridgway RA, Burke ZD, Muncan V, Clarke AR, Sansom OJ. B-catenin deficiency, but not Myc deletion, suppresses the immediate phenotypes of APC loss in the liver. Proc Natl Acad Sci USA 2008; 105: 18919-18923 [PMID: 19033191 DOI: 10.1073/pnas.0805778105]
72. Moriyama A, Kii I, Sunabori T, Kurihara S, Takayama I, Shimazaki M, Tanabe H, Oginuma M, Fukayama M, Matsuzaki Y, Saga Y, Kudo A. GFP transgenic mice reveal active canonical Wnt signal in neonatal brain and in adult liver and spleen. Genesis 2007; 45: 90-100 [PMID: 17245775 DOI: 10.1002/dvg.20268] (Pubitemid 46399464)
73. Zeng G, Awan F, Otruba W, Muller P, Apte U, Tan X, Gandhi C, Demetris AJ, Monga SP. Wnt'er in liver: expression of Wnt and frizzled genes in mouse. Hepatology 2007; 45: 195-204 [PMID: 17187422 DOI: 10.1002/hep.21473] (Pubitemid 46144379)
74. Gebhardt R, Gaunitz F, Mecke D. Heterogeneous (positional) expression of hepatic glutamine synthetase: features, regulation and implications for hepatocarcinogenesis. Adv Enzyme Regul 1994; 34: 27-56 [PMID: 7942280]
75. Jungermann K, Thurman RG. Hepatocyte heterogeneity in the metabolism of carbohydrates. Enzyme 1992; 46: 33-58 [PMID: 1289081] (Pubitemid 23032626)
76. Chafey P, Finzi L, Boisgard R, Caüzac M, Clary G, Broussard C, Pégorier JP, Guillonneau F, Mayeux P, Camoin L, Tavitian B, Colnot S, Perret C. Proteomic analysis of beta-catenin activation in mouse liver by DIGE analysis identifies glucose metabolism as a new target of the Wnt pathway. Proteomics 2009; 9: 3889-3900 [PMID: 19639598 DOI: 10.1002/pmic.200800609]
77. Austinat M, Dunsch R, Wittekind C, Tannapfel A, Gebhardt R, Gaunitz F. Correlation between beta-catenin mutations and expression of Wnt-signaling target genes in hepatocellular carcinoma. Mol Cancer 2008; 7: 21 [PMID: 18282277 DOI: 10.1186/1476-4598-7-21]
78. Häussinger D, Lamers WH, Moorman AF. Hepatocyte heterogeneity in the metabolism of amino acids and ammonia. Enzyme 1992; 46: 72-93 [PMID: 1289083]
79. Jungermann K, Kietzmann T. Zonation of parenchymal and nonparenchymal metabolism in liver. Annu Rev Nutr 1996; 16: 179-203 [PMID: 8839925 DOI: 10.1146/annurev.nu.16.070196.001143] (Pubitemid 26286852)
80. Braeuning A, Ittrich C, Köhle C, Hailfinger S, Bonin M, Buchmann A, Schwarz M. Differential gene expression in periportal and perivenous mouse hepatocytes. FEBS J 2006; 273: 5051-5061 [PMID: 17054714 DOI: 10.1111/j.1742-4658.2006.05503.x] (Pubitemid 44673296)
81. Hijmans BS, Grefhorst A, Oosterveer MH, Groen AK. Zonation of glucose and fatty acid metabolism in the liver: mechanism and metabolic consequences. Biochimie 2014; 96: 121-129 [PMID: 23792151 DOI: 10.1016/j.biochi.2013.06.007]
82. Massimi M, Lear SR, Williams DL, Jones AL, Erickson SK. Differential expression of apolipoprotein E messenger RNA within the rat liver lobule determined by in situ hybridization. Hepatology 1999; 29: 1549-1555 [PMID: 10216141 DOI: 10.1002/hep.510290504] (Pubitemid 29211059)
83. Loud AV. A quantitative stereological description of the ultrastructure of normal rat liver parenchymal cells. J Cell Biol 1968; 37: 27-46 [PMID: 5645844]
84. Wimmer M, Pette D. Microphotometric studies on intraacinar enzyme distribution in rat liver. Histochemistry 1979; 64: 23-33 [PMID: 521313] (Pubitemid 10210109)
85. Quistorff B, Grunnet N. Dual-digitonin-pulse perfusion. Concurrent sampling of periportal and perivenous cytosol of rat liver for determination of metabolites and enzyme activities. Biochem J 1987; 243: 87-95 [PMID: 3606584] (Pubitemid 17048887)
86. Tosh D, Alberti GM, Agius L. Glucagon regulation of gluconeogenesis and ketogenesis in periportal and perivenous rat hepatocytes. Heterogeneity of hormone action and of the mitochondrial redox state. Biochem J 1988; 256: 197-204 [PMID: 3223900]
87. Lehwald N, Tao GZ, Jang KY, Papandreou I, Liu B, Liu B, Pysz MA, Willmann JK, Knoefel WT, Denko NC, Sylvester KG. β-Catenin regulates hepatic mitochondrial function and energy balance in mice. Gastroenterology 2012; 143: 754-764 [PMID: 22684045 DOI: 10.1053/j.gastro.2012.05.048]
88. Ring JA, Ghabrial H, Ching MS, Smallwood RA, Morgan DJ. Fetal hepatic drug elimination. Pharmacol Ther 1999; 84: 429-445 [PMID: 10665839]
89. Lindros KO. Zonation of cytochrome P450 expression, drug metabolism and toxicity in liver. Gen Pharmacol 1997; 28: 191-196 [PMID: 9013193] (Pubitemid 27016124)
90. Roberts MS, Magnusson BM, Burczynski FJ, Weiss M. Enterohepatic circulation: physiological, pharmacokinetic and clinical implications. Clin Pharmacokinet 2002; 41: 751-790 [PMID: 12162761 DOI: 10.2165/00003088-200241100-00005] (Pubitemid 34948196)
91. Braeuning A. Regulation of cytochrome P450 expression by Ras- and beta-catenin-dependent signaling. Curr Drug Metab 2009; 10: 138-158 [PMID: 19275549]
92. Braeuning A, Heubach Y, Knorpp T, Kowalik MA, Templin M, Columbano A, Schwarz M. Gender-specific interplay of signaling through β-catenin and CAR in the regulation of xenobiotic-induced hepatocyte proliferation. Toxicol Sci 2011; 123: 113-122 [PMID: 21705713 DOI: 10.1093/toxsci/kfr166]
93. Braeuning A, Schwarz M. beta-Catenin as a multilayer modulator of zonal cytochrome P450 expression in mouse liver. Biol Chem 2010; 391: 139-148 [PMID: 20030591 DOI: 10.1515/BC.2010.012]
94. Giera S, Braeuning A, Köhle C, Bursch W, Metzger U, Buchmann A, Schwarz M. Wnt/beta-catenin signaling activates and determines hepatic zonal expression of glutathione S-transferases in mouse liver. Toxicol Sci 2010; 115: 22-33 [PMID: 20118494 DOI: 10.1093/toxsci/kfq033]
95. van der Vos KE, Coffer PJ. Glutamine metabolism links growth factor signaling to the regulation of autophagy. Autophagy 2012; 8: 1862-1864 [PMID: 22996802 DOI: 10.4161/auto.22152]
96. Gebhardt R, Coffer PJ. Hepatic autophagy is differentially regulated in periportal and pericentral zones - a general mechanism relevant for other tissues? Cell Commun Signal 2013; 11: 21 [PMID: 23531205 DOI: 10.1186/1478-811X-11-21]
97. Louro ID, McKie-Bell P, Gosnell H, Brindley BC, Bucy RP, Ruppert JM. The zinc finger protein GLI induces cellular sensitivity to the mTOR inhibitor rapamycin. Cell Growth Differ 1999; 10: 503-516 [PMID: 10437918] (Pubitemid 29344692)
98. Wang Y, Ding Q, Yen CJ, Xia W, Izzo JG, Lang JY, Li CW, Hsu JL, Miller SA, Wang X, Lee DF, Hsu JM, Huo L, Labaff AM, Liu D, Huang TH, Lai CC, Tsai FJ, Chang WC, Chen CH, Wu TT, Buttar NS, Wang KK, Wu Y, Wang H, Ajani J, Hung MC. The crosstalk of mTOR/S6K1 and Hedgehog pathways. Cancer Cell 2012; 21: 374-387 [PMID: 22439934 DOI: 10.1016/j.ccr.2011.12.028]
99. van Heemst D, Beekman M, Mooijaart SP, Heijmans BT, Brandt BW, Zwaan BJ, Slagboom PE, Westendorp RG. Reduced insulin/IGF-1 signalling and human longevity. Aging Cell 2005; 4: 79-85 [PMID: 15771611 DOI: 10.1111/j.1474-9728.2005.00148.x] (Pubitemid 41632906)
100. Bartke A. Pleiotropic effects of growth hormone signaling in aging. Trends Endocrinol Metab 2011; 22: 437-442 [PMID: 21852148 DOI: 10.1016/j.tem.2011.07.004]
101. Sokolović M, Sokolović A, Wehkamp D, Ver Loren van Themaat E, de Waart DR, Gilhuijs-Pederson LA, Nikolsky Y, van Kampen AH, Hakvoort TB, Lamers WH. The transcriptomic signature of fasting murine liver. BMC Genomics 2008; 9: 528 [PMID: 18990241 DOI: 10.1186/1471-2164-9-528]
102. Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell 2005; 120: 483-495 [PMID: 15734681 DOI: 10.1016/j.cell.2005.02.001] (Pubitemid 40269763)
103. Marí M, Colell A, Morales A, von Montfort C, Garcia-Ruiz C, Fernández-Checa JC. Redox control of liver function in health and disease. Antioxid Redox Signal 2010; 12: 1295-1331 [PMID: 19803748 DOI: 10.1089/ars.2009.2634]
104. Lenart J, Dombrowski F, Görlach A, Kietzmann T. Deficiency of manganese superoxide dismutase in hepatocytes disrupts zonated gene expression in mouse liver. Arch Biochem Biophys 2007; 462: 238-244 [PMID: 17367743 DOI: 10.1016/j.abb.2007.02.007] (Pubitemid 46856321)
105. Hoogeboom D, Burgering BM. Should I stay or should I go: beta-catenin decides under stress. Biochim Biophys Acta 2009; 1796: 63-74 [PMID: 19268509 DOI: 10.1016/j.bbcan.2009.02.002]
106. Pessayre D, Fromenty B. NASH: a mitochondrial disease. J Hepatol 2005; 42: 928-940 [PMID: 15885365 DOI: 10.1016/j.jhep.2005.03.004] (Pubitemid 40693212)
107. von Montfort C, Matias N, Fernandez A, Fucho R, Conde de la Rosa L, Martinez-Chantar ML, Mato JM, Machida K, Tsukamoto H, Murphy MP, Mansouri A, Kaplowitz N, Garcia-Ruiz C, Fernandez-Checa JC. Mitochondrial GSH determines the toxic or therapeutic potential of superoxide scavenging in steatohepatitis. J Hepatol 2012; 57: 852-859 [PMID: 22687340 DOI: 10.1016/j.jhep.2012.05.024]
108. Braeuning A, Schwarz M. Zonation of heme synthesis enzymes in mouse liver and their regulation by β-catenin and Ha-ras. Biol Chem 2010; 391: 1305-1313 [PMID: 20707599 DOI: 10.1515/bc.2010.115]
109. Zou Z, Ekataksin W, Wake K. Zonal and regional differences identified from precision mapping of vitamin A-storing lipid droplets of the hepatic stellate cells in pig liver: a novel concept of addressing the intralobular area of heterogeneity. Hepatology 1998; 27: 1098-1108 [PMID: 9537451 DOI: 10.1002/hep.510270427] (Pubitemid 28160497)
110. Hattersley AT. Prime suspect: the TCF7L2 gene and type 2 diabetes risk. J Clin Invest 2007; 117: 2077-2079 [PMID: 17671643 DOI: 10.1172/JCI33077] (Pubitemid 47219548)
111. Cauchi S, El Achhab Y, Choquet H, Dina C, Krempler F, Weitgasser R, Nejjari C, Patsch W, Chikri M, Meyre D, Froguel P. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med (Berl) 2007; 85: 777-782 [PMID: 17476472 DOI: 10.1007/s00109-007-0203-4] (Pubitemid 47063530)
112. Schinner S. Wnt-signalling and the metabolic syndrome. Horm Metab Res 2009; 41: 159-163 [PMID: 19214925 DOI: 10.1055/s-0028-1119408]
113. Bartl M, Pfaff M, Toepfer S, Zellmer S, Gebhardt R, Schuster S, Li P. Crossing Borders within the ABC - Automation, Biomedical Engineering and Computer Science: Model-based optimization to explain liver zonation in nitrogen metabolism. In: Scharff P, editor. International science colloquium. Ilmenau: ISLE-Verl, 2010: 235-240
114. Comar JF, Suzuki-Kemmelmeier F, Constantin J, Bracht A. Hepatic zonation of carbon and nitrogen fluxes derived from glutamine and ammonia transformations. J Biomed Sci 2010; 17: 1 [PMID: 20055990 DOI: 10.1186/1423-0127-17-1]
115. Fedorova E, Zink D. Nuclear architecture and gene regulation. Biochim Biophys Acta 2008; 1783: 2174-2184 [PMID: 18718493 DOI: 10.1016/j.bbamcr.2008.07.018]
116. Ravasi T, Suzuki H, Cannistraci CV, Katayama S, Bajic VB, Tan K, Akalin A, Schmeier S, Kanamori-Katayama M, Bertin N, Carninci P, Daub CO, Forrest AR, Gough J, Grimmond S, Han JH, Hashimoto T, Hide W, Hofmann O, Kamburov A, Kaur M, Kawaji H, Kubosaki A, Lassmann T, van Nimwegen E, MacPherson CR, Ogawa C, Radovanovic A, Schwartz A, Teasdale RD, Tegnér J, Lenhard B, Teichmann SA, Arakawa T, Ninomiya N, Murakami K, Tagami M, Fukuda S, Imamura K, Kai C, Ishihara R, Kitazume Y, Kawai J, Hume DA, Ideker T, Hayashizaki Y. An atlas of combinatorial transcriptional regulation in mouse and man. Cell 2010; 140: 744-752 [PMID: 20211142 DOI: 10.1016/j.cell.2010.01.044]
117. Truica CI, Byers S, Gelmann EP. Beta-catenin affects androgen receptor transcriptional activity and ligand specificity. Cancer Res 2000; 60: 4709-4713 [PMID: 10987273]
118. Mulholland DJ, Dedhar S, Coetzee GA, Nelson CC. Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know? Endocr Rev 2005; 26: 898-915 [PMID: 16126938 DOI: 10.1210/er.2003-0034] (Pubitemid 41770157)
119. Colletti M, Cicchini C, Conigliaro A, Santangelo L, Alonzi T, Pasquini E, Tripodi M, Amicone L. Convergence of Wnt signaling on the HNF4alpha-driven transcription in controlling liver zonation. Gastroenterology 2009; 137: 660-672 [PMID: 19454287 DOI: 10.1053/j.gastro.2009.05.038]
120. Lindros KO, Oinonen T, Issakainen J, Nagy P, Thorgeirsson SS. Zonal distribution of transcripts of four hepatic transcription factors in the mature rat liver. Cell Biol Toxicol 1997; 13: 257-262 [PMID: 9298246] (Pubitemid 27373396)
121. Stanulović VS, Kyrmizi I, Kruithof-de Julio M, Hoogenkamp M, Vermeulen JL, Ruijter JM, Talianidis I, Hakvoort TB, Lamers WH. Hepatic HNF4alpha deficiency induces periportal expression of glutamine synthetase and other pericentral enzymes. Hepatology 2007; 45: 433-444 [PMID: 17256722 DOI: 10.1002/hep.21456]
122. Kornmann B, Schaad O, Bujard H, Takahashi JS, Schibler U. System-driven and oscillator-dependent circadian transcription in mice with a conditionally active liver clock. PLoS Biol 2007; 5: e34 [PMID: 17298173 DOI: 10.1371/journal.pbio.0050034]
123. Ando H, Takamura T, Matsuzawa-Nagata N, Shima KR, Nakamura S, Kumazaki M, Kurita S, Misu H, Togawa N, Fukushima T, Fujimura A, Kaneko S. The hepatic circadian clock is preserved in a lipid-induced mouse model of non-alcoholic steatohepatitis. Biochem Biophys Res Commun 2009; 380: 684-688 [PMID: 19285022 DOI: 10.1016/j.bbrc.2009.01.150]
124. Hirao J, Nishimura M, Arakawa S, Niino N, Mori K, Furukawa T, Sanbuissho A, Manabe S, Nishihara M, Mori Y. Sex and circadian modulatory effects on rat liver as assessed by transcriptome analyses. J Toxicol Sci 2011; 36: 9-22 [PMID: 21297337]
125. Schmutz I, Albrecht U, Ripperger JA. The role of clock genes and rhythmicity in the liver. Mol Cell Endocrinol 2012; 349: 38-44 [PMID: 21664421 DOI: 10.1016/j.mce.2011.05.007]
126. Sasse D. Dynamics of liver glycogen: the topochemistry of glycogen synthesis, glycogen content and glycogenolysis under the experimental conditions of glycogen accumulation and depletion. Histochemistry 1975; 45: 237-254 [PMID: 814113]
127. Häussinger D. Regulation of hepatic ammonia metabolism: the intercellular glutamine cycle. Adv Enzyme Regul 1986; 25: 159-180 [PMID: 2880476]
128. Bur IM, Cohen-Solal AM, Carmignac D, Abecassis PY, Chauvet N, Martin AO, van der Horst GT, Robinson IC, Maurel P, Mollard P, Bonnefont X. The circadian clock components CRY1 and CRY2 are necessary to sustain sex dimorphism in mouse liver metabolism. J Biol Chem 2009; 284: 9066-9073 [PMID: 19211562 DOI: 10.1074/jbc.M808360200]
129. Waxman DJ, Holloway MG. Sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol 2009; 76: 215-228 [PMID: 19483103 DOI: 10.1124/mol.109.056705]
130. Lorbek G, Perše M, Horvat S, Björkhem I, Rozman D. Sex differences in the hepatic cholesterol sensing mechanisms in mice. Molecules 2013; 18: 11067-11085 [PMID: 24025456 DOI: 10.3390/molecules180911067]
131. Lu YF, Jin T, Xu Y, Zhang D, Wu Q, Zhang YK, Liu J. Sex differences in the circadian variation of cytochrome p450 genes and corresponding nuclear receptors in mouse liver. Chronobiol Int 2013; 30: 1135-1143 [PMID: 23926955 DOI: 10.3109/07420528.2013.805762]
132. Sirma H, Williams GM, Gebhardt R. Strain- and sex-specific variations in hepatic glutamine synthetase activity and distribution in rats and mice. Liver 1996; 16: 166-173 [PMID: 8873003] (Pubitemid 26280483)